In line with its multilateral commitments, and in order to contribute to the equitable distribution of COVID-19 vaccines, Luxembourg has decided to increase its financial support for the working axes of the ACT-A Accelerator, in particular for COVAX, the vaccine working axis, led by Gavi, through a financial contribution of EUR 4 million to its market commitment instrument.